A clinical-stage biotechnology company focused on developing genetically targeted therapies for cardiovascular diseases. Its lead programs have historically centered on precision medicine approaches for conditions such as atrial fibrillation and heart failure, using genetic markers to identify respo...
No congressional trades have been disclosed for Advisor Bio Company (ABIO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.